Demonstrates a stability-indicating RP-HPLC method for estimating Luliconazole and Salicylic Acid in pharmaceutical dosage form, indicating its quality control suitability.
A simple, rapid, precise, and stability-indicating RP-HPLC method was developed and validated for the simultaneous estimation of Luliconazole and Salicylic Acid in pharmaceutical dosage form. Separation was achieved on a YMC Pack ODS-A column (150 mm × 4.6 mm, 5 µm) using Buffer: Methanol (30:70 % v/v) as mobile phase at a flow rate of 1.0 mL/min, with detection at 226 nm. The method showed excellent linearity in the range of 10–30 µg/mL for Luliconazole and 30–90 µg/mL for Salicylic Acid (R² > 0.998). Accuracy studies showed recoveries of 98% and 99.6%, respectively. LOD and LOQ values indicated good sensitivity. Forced degradation studies under various stress conditions confirmed the stability-indicating nature of the method, with clear separation of degradation products. The method is suitable for routine quality control analysis.
No takes yet. Share an insight, caveat, or question.
Riya Dasadiya2 Manisha Kotadiya*1 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: